适应证-话题@MedSci

#适应证#

55篇内容 | 2122人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1893582, encodeId=2fdf189358293, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=FDA扩美敦力CRT适应证, objectType=article, longId=33444, objectId=1937334448f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1937334448f, replyNumber=0, likeNumber=55, createdTime=2014-05-17, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1937334448f, moduleTitle=FDA扩美敦力CRT适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1937334448f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893583, encodeId=b9f01893583bf, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=OCC 2014：TAVR稳步发展适应证级别不断提升, objectType=article, longId=36061, objectId=a22036061d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a22036061d7, replyNumber=0, likeNumber=76, createdTime=2015-01-15, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a22036061d7, moduleTitle=OCC 2014：TAVR稳步发展适应证级别不断提升, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a22036061d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893581, encodeId=7dc7189358186, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=王建安：经导管主动脉瓣置入术（TAVI）的手术适应证及技术要点, objectType=article, longId=21103, objectId=5f032110345, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f032110345, replyNumber=0, likeNumber=65, createdTime=2014-04-12, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f032110345, moduleTitle=王建安：经导管主动脉瓣置入术（TAVI）的手术适应证及技术要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f032110345)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893580, encodeId=f42d189358018, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=JAMA：单腔ICD植入用于无起搏器适应证患者一级预防优于双腔ICD, objectType=article, longId=19723, objectId=752f19e23fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=752f19e23fa, replyNumber=0, likeNumber=63, createdTime=2014-01-20, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=752f19e23fa, moduleTitle=JAMA：单腔ICD植入用于无起搏器适应证患者一级预防优于双腔ICD, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=752f19e23fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893579, encodeId=f18618935e99c, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=FDA扩大艾曲泊帕适应证, objectType=article, longId=12696, objectId=ca071269664, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca071269664, replyNumber=0, likeNumber=58, createdTime=2013-06-04, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca071269664, moduleTitle=FDA扩大艾曲泊帕适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca071269664)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893577, encodeId=302818935e788, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=贝伐珠单抗新适应证有望获EMA批准, objectType=article, longId=10619, objectId=e5e11061918, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e11061918, replyNumber=0, likeNumber=79, createdTime=2013-03-04, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e11061918, moduleTitle=贝伐珠单抗新适应证有望获EMA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e11061918)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893578, encodeId=ae7f18935e84b, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=欧盟限制吡美莫司适应证外使用, objectType=article, longId=11935, objectId=375e1193543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=375e1193543, replyNumber=0, likeNumber=51, createdTime=2013-08-28, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=375e1193543, moduleTitle=欧盟限制吡美莫司适应证外使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=375e1193543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893575, encodeId=00d118935e542, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=伊伐布雷定：减慢心率又添适应证, objectType=article, longId=6655, objectId=aa5c665590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa5c665590, replyNumber=0, likeNumber=61, createdTime=2012-10-26, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa5c665590, moduleTitle=伊伐布雷定：减慢心率又添适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa5c665590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893574, encodeId=9e7418935e420, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=强生拜耳的拜瑞妥（Xarelto）新适应证申请遭FDA评审委员会拒绝, objectType=article, longId=6484, objectId=92836484f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92836484f5, replyNumber=0, likeNumber=50, createdTime=2013-03-08, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92836484f5, moduleTitle=强生拜耳的拜瑞妥（Xarelto）新适应证申请遭FDA评审委员会拒绝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92836484f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893572, encodeId=dfeb18935e297, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=FDA优先审查利伐沙班和阿哌沙班新适应证, objectType=article, longId=4295, objectId=ced84295fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced84295fb, replyNumber=0, likeNumber=91, createdTime=2012-11-14, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced84295fb, moduleTitle=FDA优先审查利伐沙班和阿哌沙班新适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced84295fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893576, encodeId=92b118935e630, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=FDA扩大Sapien人工瓣膜适应证, objectType=article, longId=10559, objectId=77af10559a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77af10559a7, replyNumber=0, likeNumber=61, createdTime=2013-09-07, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77af10559a7, moduleTitle=FDA扩大Sapien人工瓣膜适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77af10559a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893571, encodeId=29cb18935e12f, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=欧盟EMA调整多种抗肿瘤药物的适应证和禁忌证, objectType=article, longId=3364, objectId=b122336400, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b122336400, replyNumber=0, likeNumber=61, createdTime=2012-04-16, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b122336400, moduleTitle=欧盟EMA调整多种抗肿瘤药物的适应证和禁忌证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b122336400)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893570, encodeId=6c7518935e0ab, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=FDA取消安维汀（贝伐珠单抗）治疗乳腺癌的适应证, objectType=article, longId=3357, objectId=1026335e60, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1026335e60, replyNumber=0, likeNumber=80, createdTime=2012-11-05, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1026335e60, moduleTitle=FDA取消安维汀（贝伐珠单抗）治疗乳腺癌的适应证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1026335e60)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893573, encodeId=520f18935e3b2, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=2012HRS/EHRA/ECAS专家共识房颤消融适应证全新推荐, objectType=article, longId=4464, objectId=5e36446419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e36446419, replyNumber=0, likeNumber=52, createdTime=2013-02-11, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e36446419, moduleTitle=2012HRS/EHRA/ECAS专家共识房颤消融适应证全新推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e36446419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893568, encodeId=9cd41893568c1, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=CRT﹠CRT-D ：适应证拓展是否过于匆忙？, objectType=article, longId=2562, objectId=fb422562e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb422562e9, replyNumber=0, likeNumber=45, createdTime=2012-01-16, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb422562e9, moduleTitle=CRT﹠CRT-D ：适应证拓展是否过于匆忙？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb422562e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893569, encodeId=b19b189356927, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=何奔：心脏CT滥用问题及适应证把握, objectType=article, longId=3187, objectId=b298318e73, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b298318e73, replyNumber=0, likeNumber=60, createdTime=2012-01-07, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b298318e73, moduleTitle=何奔：心脏CT滥用问题及适应证把握, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b298318e73)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1893567, encodeId=aba8189356e64, content=<a href='/topic/show?id=cecf94e17f9' target=_blank style='color:#2F92EE;'>#适应证#</a>, objectTitle=CRT﹠CRT-D ：适应证拓展是否过于匆忙？, objectType=article, longId=2533, objectId=af392533a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af392533a6, replyNumber=0, likeNumber=67, createdTime=2012-03-09, rootId=0, userName=muzishouyi, userId=685a124, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af392533a6, moduleTitle=CRT﹠CRT-D ：适应证拓展是否过于匆忙？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af392533a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

适应证

2020-05-29

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

FDA扩美敦力CRT适应证

2014-05-17

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

OCC 2014：TAVR稳步发展适应证级别不断提升

2015-01-15

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

王建安：经导管主动脉瓣置入术（TAVI）的手术适应证及技术要点

2014-04-12

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

JAMA：单腔ICD植入用于无起搏器适应证患者一级预防优于双腔ICD

2014-01-20

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

FDA扩大艾曲泊帕适应证

2013-06-04

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

贝伐珠单抗新适应证有望获EMA批准

2013-03-04

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

欧盟限制吡美莫司适应证外使用

2013-08-28

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

伊伐布雷定：减慢心率又添适应证

2012-10-26

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

强生拜耳的拜瑞妥（Xarelto）新适应证申请遭FDA评审委员会拒绝

2013-03-08

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

FDA优先审查利伐沙班和阿哌沙班新适应证

2012-11-14

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

FDA扩大Sapien人工瓣膜适应证

2013-09-07

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

欧盟EMA调整多种抗肿瘤药物的适应证和禁忌证

2012-04-16

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

FDA取消安维汀（贝伐珠单抗）治疗乳腺癌的适应证

2012-11-05

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

2012HRS/EHRA/ECAS专家共识房颤消融适应证全新推荐

2013-02-11

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

CRT﹠CRT-D ：适应证拓展是否过于匆忙？

2012-01-16

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

何奔：心脏CT滥用问题及适应证把握

2012-01-07

muzishouyi (审核中...)

前往app查看评论内容

#适应证#

CRT﹠CRT-D ：适应证拓展是否过于匆忙？

2012-03-09

科室
- - 订阅+
  - 更多科室
工具
服务